Academy Research Conference 2024: Advances in Implantable Devices

Registration is now open!

Register Now

For detail about the presentations and to access registration, please visit the registration site.

Chair

René H. Gifford, PhD
Fred H. Bess Chair in Audiology, Professor, and Director, Hearing and Speech Sciences, Implantables, Hearing Enhancement, and Amplification Research (I HEAR) Laboratory Vanderbilt University Medical Center

Program Committee

• Camille Dunn-Johnson, PhD
  Associate Professor and Director of the Cochlear Implant Program, University of Iowa
• Michelle Hughes, PhD
  Professor and Director of the Cochlear Implant Research Lab, University of Nebraska, Lincoln
• Jamie Bogle, AuD, PhD
  Principal Investigator, ARC Grant, Chair, Division of Audiology and Assistant Professor, Mayo Clinic College of Medicine Science

Conference Overview

There’s a 17- to 25-year gap between scientific discovery and clinical adoption of new and effective interventions. For children with congenital hearing loss, a two-decade delay for data-driven advancements in diagnostic and habilitative audiological practices can have devastating effects on auditory, speech, language, academic, and social development. Adults with hearing loss also are at risk for impaired communication, social isolation, educational and vocational barriers, dementia, and poor quality of life. Since auditory implantable technology is rapidly advancing, and candidacy indications are both expanding and overlapping, attempting to stay up-to-date on the literature becomes a part-time job, which is particularly difficult for full-time clinicians.

The 2024 Virtual Academy Research Conference (ARC) will bring together the latest discovery in auditory implantable technology from an esteemed group of clinician-scientists in audiology and otology. We will be covering topics including advances in auditory implant surgery, asymmetrically driven neuroplasticity for bimodal and sequential bilateral cochlear implant (CI) recipients, the role of genetics in clinical decision-making for candidacy determination and recommended intervention, totally implantable technology, single-sided deafness (SSD), highly asymmetric hearing losses, and much more.

Program

• Morning Session 10:00 am–12:30 pm ET
• Afternoon Session 1:00–3:30 pm ET
• CEUs:
  .25 Tier 1 CEUs for morning or afternoon session
  .5 Tier 1 CEUs for full-day program

View Full Schedule

Registration

Available for half-day, full-day, or on-demand only.

Funding for this conference was made possible [in part] by 1R13DC020893-01 from National Institute of Deafness and Other Communication Disorders.